---
figid: PMC2758728__zeg0100968140006
figtitle: Mechanism of the inhibition by 8-Cl-ADO in B-lymphocytes
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2758728
filename: zeg0100968140006.jpg
figlink: /pmc/articles/PMC2758728/figure/F6/
number: F6
caption: Mechanism of the inhibition by 8-Cl-ADO in B-lymphocytes. 1, 8-Cl-ADO is
  transported intracellularly by an es-type ENT protein and metabolized to ADOHcy
  to () induce apoptosis. 3), Extracellular 8-Cl-ADO alters the action of A1, A2a,
  and A2b adenosine receptors that () activate or inhibit PKA. 5), PKA is stimulated
  extracellularly at GPCRs by ISO or intracellularly at () adenyl cyclase by forskolin
  (Fsk). 7), Growth factors or cytokines activate GPCRs to stimulate the ERK1/2 cascade
  of the MAPK signaling pathway. 8) LPA stimulates GPCRs that interact with RTK that
  activate ERK1/2. 9) PKA interacts with c-Raf-1 or B-Raf of the ERK1/2 MAPK pathway
  to stimulate or inhibit cell proliferation. 10, 8-Cl-ADO alters the activity of
  PKA.
papertitle: '8-Cl-Adenosine Inhibits Proliferation and Causes Apoptosis in B-Lymphocytes
  via Protein Kinase A-Dependent and Independent Effects: Implications for Treatment
  of Carney Complex-Associated Tumors.'
reftext: Audrey J. Robinson-White, et al. J Clin Endocrinol Metab. 2009 Oct;94(10):4061-4069.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.955524
figid_alias: PMC2758728__F6
figtype: Figure
redirect_from: /figures/PMC2758728__F6
ndex: 8cc3124f-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2758728__zeg0100968140006.html
  '@type': Dataset
  description: Mechanism of the inhibition by 8-Cl-ADO in B-lymphocytes. 1, 8-Cl-ADO
    is transported intracellularly by an es-type ENT protein and metabolized to ADOHcy
    to () induce apoptosis. 3), Extracellular 8-Cl-ADO alters the action of A1, A2a,
    and A2b adenosine receptors that () activate or inhibit PKA. 5), PKA is stimulated
    extracellularly at GPCRs by ISO or intracellularly at () adenyl cyclase by forskolin
    (Fsk). 7), Growth factors or cytokines activate GPCRs to stimulate the ERK1/2
    cascade of the MAPK signaling pathway. 8) LPA stimulates GPCRs that interact with
    RTK that activate ERK1/2. 9) PKA interacts with c-Raf-1 or B-Raf of the ERK1/2
    MAPK pathway to stimulate or inhibit cell proliferation. 10, 8-Cl-ADO alters the
    activity of PKA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - Col4a1
  - Ca-alpha1D
  - alphaTub84B
  - nAChRalpha1
  - wb
  - Prosalpha1
  - gig
  - gs
  - Tie
  - Ras85D
  - InR
  - ras
  - Ras64B
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - LPA
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - ADRA1D
  - IGKV2D-29
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - NT5E
  - GAN
  - GNAS
  - GNAL
  - KRAS
  - HRAS
  - NRAS
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - Adenosine
  - homocysteine
---
